Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Existing studies generally suggest that, by alleviating the obesity/IRhyperandrogenism cascade, GLP-1RAs bring the HPO axis closer to a physiological state
People with higher BMI (body mass index) or severe insulin resistance may take more time to experience significant weight reduction
Patients with a history of pancreatitis require careful assessment before starting treatment
Compared to PEGylation (which only prolongs circulation) or antibody conjugation (which carries immunogenic risk), membrane-coating achieves ~ 23-fold higher renal accumulation efficiency and reduces systemic toxicity by avoiding protein corona-induced nonspecific adsorption
Improvements in several metabolic parameters were documented, including decreased postprandial insulin, and a profile of gut hormones favouring control of appetite (increased fasting GLP-1 and GIP, increased postprandial GLP-1 and a decreased ratio of ghrelin:GLP-1), compared to a low-fat diet [11]
